Rossi G P, Colonna S, Pavan E, Albertin G, Della Rocca F, Gerosa G, Casarotto D, Sartore S, Pauletto P, Pessina A C
Departments of Clinical and Experimental Medicine, Cardiac Surgery University of Padova, Italy.
Circulation. 1999 Mar 9;99(9):1147-55. doi: 10.1161/01.cir.99.9.1147.
The participation of endothelin-1 (ET-1) in the control of vascular tone in humans has been questioned, on the basis of the finding of subthreshold immunoreactive (ir) ET-1 plasma levels. However, because most ET-1 is secreted abluminally, it might attain a higher concentration in the tunica media than in plasma. Furthermore, evidence indicates that vascular smooth muscle cells (VSMCs) can synthesize ET-1 on stimulation in vitro. We therefore looked for irET-1 in the different layers of the wall of human arteries, including renal, gastric, and internal thoracic artery wall, obtained ex vivo from consenting patients with coronary artery disease and/or high blood pressure undergoing surgery, as well as from young organ donors.
We performed immunohistochemistry with specific anti-ET-1 and anti-vWF antibodies followed by detection with an avidin-biotin complex ultrasensitive kit. The presence of preproET-1 and human endothelin-converting enzyme-1 (hECE-1) mRNA was also investigated by reverse transcription-polymerase chain reaction in homogenates of vessel wall, including preparations deprived of both endothelium and adventitia, and in isolated VSMCs. We detected irET-1 in the endothelium of all arteries and in the tunica media of internal thoracic artery from most patients with coronary artery disease. PreproET-1 and hECE-1 mRNA was also detected in VSMCs isolated from these vessels. irET-1 and irvWF staining in endothelium and tunica media was measured by use of microscope-coupled computer-assisted technology. Significant correlations between the amount of irET-1 in the tunica media and mean blood pressure (P<0.05), total serum cholesterol (P<0.05), and number of atherosclerotic sites (P<0.001) were found. Thus, in organ donors, irET-1 was detectable almost exclusively in endothelial cells, whereas in patients with coronary artery disease and/or arterial hypertension, sizable amounts of irET-1 were detectable in the tunica media of different types of arteries. In addition, VSMCs isolated from these vessels coexpressed the preproET-1 and hECE-1 genes.
Collectively, these findings are consistent with the contention that endothelial damage occurs in most patients with atherosclerosis and/or hypertension and that ET-1 is synthesized in VSMCs of these patients.
基于血浆中免疫反应性内皮素-1(irET-1)水平低于阈值这一发现,内皮素-1(ET-1)在人体血管张力控制中的作用受到质疑。然而,由于大多数ET-1是从血管腔外分泌的,它在中膜中的浓度可能高于血浆中的浓度。此外,有证据表明血管平滑肌细胞(VSMC)在体外受到刺激时可以合成ET-1。因此,我们在从接受手术的冠心病和/或高血压患者以及年轻器官捐赠者中离体获取的人体动脉壁的不同层中寻找irET-1,这些动脉包括肾动脉、胃动脉和胸内动脉。
我们使用特异性抗ET-1和抗血管性血友病因子(vWF)抗体进行免疫组织化学,然后用抗生物素蛋白-生物素复合物超敏试剂盒进行检测。还通过逆转录-聚合酶链反应在血管壁匀浆(包括去除内皮和外膜的标本)以及分离的VSMC中研究前内皮素原-1(preproET-1)和人内皮素转换酶-1(hECE-1)mRNA的存在情况。我们在所有动脉的内皮以及大多数冠心病患者胸内动脉的中膜中检测到了irET-1。在从这些血管分离的VSMC中也检测到了preproET-1和hECE-1 mRNA。通过显微镜耦合计算机辅助技术测量内皮和中膜中的irET-1和irvWF染色。发现中膜中irET-1的量与平均血压(P<0.05)、总血清胆固醇(P<0.05)和动脉粥样硬化部位数量(P<0.001)之间存在显著相关性。因此,在器官捐赠者中,几乎仅在内皮细胞中可检测到irET-1,而在冠心病和/或动脉高血压患者中,在不同类型动脉的中膜中可检测到大量的irET-1。此外,从这些血管分离的VSMC共表达preproET-1和hECE-1基因。
总体而言,这些发现与以下观点一致,即大多数动脉粥样硬化和/或高血压患者存在内皮损伤,并且这些患者的VSMC中合成了ET-1。